BEIJING, March 12 (Xinhua) — From 2021 to 2023, more than 3.7 million heart disease patients received implants utilizing discounted stents purchased through China\’s bulk procurement program, accordin
Tag: NHSA
Centralized procurement cuts insulin prices, benefits millions of diabetes patients
A production line of anti-diabetes injection is pictured at a workshop of Novo Nordisk (China) Pharmaceutical Co., Ltd. in Tianjin, north China, Sept. 22, 2022. (Xinhua/Li Ran)
BEIJING, April 22 (Xinh